½ÃÀ庸°í¼­
»óǰÄÚµå
1595209

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå : Á¦Ç°º°, ¼ÒÀ纰 - ¼¼°è ¿¹Ãø(2025-2030³â)

Parenteral Products Packaging Market by Product (Ampoules, Bags, Bottles), Material (Glass, Plastic, Polymer) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 139¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 154¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.51%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 281¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀº ±ÙÀ° ³», Á¤¸Æ ³», ÇÇÇÏ, Çdz» µî °æ±¸ ÀÌ¿ÜÀÇ °æ·Î·Î Åõ¿©µÇ´Â ¾àǰÀÇ Æ÷Àå¿¡ »ç¿ëµÇ´Â ¿ë±â ¹× Àç·áÀÇ °³¹ß ¹× °ø±Þ°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÀǾàǰÀÇ ¾ÈÁ¤¼º, ¹«±Õ¼º, ¾ÈÀü¼ºÀ» º¸ÀåÇÏ´Â µ¿½Ã¿¡ È¿°úÀûÀÎ À¯Åë°ú Åõ¿©¸¦ ÃËÁøÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ¹Ýµå½Ã ÇÊ¿äÇÑ ½ÃÀåÀÔ´Ï´Ù. ÁÖ¿ä ¿ëµµ´Â º´¿ø, Áø·á¼Ò, ÀçÅÃÄ¡·á ȯ°æ µî Á¤È®ÇÑ ¾à¹° Àü´Þ ½Ã½ºÅÛÀÌ ÇÊ¿äÇÑ ÀÇ·á ȯ°æÀ» Æ÷ÇÔÇϸç, ÃÖÁ¾ »ç¿ëÀÚ´Â Á¦¾à ȸ»ç, »ý¸í °øÇÐ ±â¾÷¿¡¼­ °øÁß º¸°Ç ±â°ü¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ È®»ê, »ý¹°ÇÐÀû Á¦Á¦ÀÇ ¹ßÀü, Çõ½ÅÀûÀÎ ¾à¹° Àü´Þ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è °í·ÉÈ­·Î ÀÎÇØ ÁÖ»çÁ¦¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸é¼­ ÀÌ·¯ÇÑ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÷´Ü Æ÷Àå¿¡´Â Àç·á °úÇÐÀÇ ¹ßÀüÀ¸·Î º¸´Ù Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ Æ÷Àå ¿É¼ÇÀ» Á¦°øÇϰí, ¾à¹° ÃßÀû ¹× ȯÀÚ ¼øÀÀµµ¸¦ Çâ»ó½ÃŰ´Â ½º¸¶Æ® Æ÷Àå ±â¼úÀÇ µµÀÔÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, Á¦Ç° º¸Á¸¼ºÀ» Çâ»ó½ÃŰ´Â º¸È£ Æ÷Àå°ú »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀεµ Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ³ôÀº Æ÷ÀåÀç ºñ¿ë, ¿À¿° ¹× Á¦Ç° ȸ¼ö À§Çè µîÀÌ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ º¹À⼺Àº ÀÌ·¯ÇÑ ¹®Á¦¸¦ ´õ¿í °¡Áß½ÃŰ°í ³ôÀº ¼öÁØÀÇ ±ÔÁ¤ Áؼö¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ¿¬±¸°³¹ßÀº ȯÀÚÀÇ ¾ÈÀü°ú ÆíÀǼºÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â Áö¼Ó °¡´ÉÇÑ Àç·á¿Í ÀÚ°¡Åõ¿© ÆÐŰÁö¸¦ °³¹ßÇÏ´Â µ¥ Àü³äÇÔÀ¸·Î½á ¹ßÀüÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú Áö¼Ó°¡´É¼º ¹× ȯÀÚ Á᫐ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÁýÁßÀ» Ư¡À¸·Î ÇÏ´Â ¸Å¿ì ¿ªµ¿ÀûÀÎ »óȲÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. °æÀï·ÂÀ» À¯ÁöÇϰíÀÚ ÇÏ´Â ±â¾÷µéÀº Â÷¼¼´ë ÆÐŰ¡ ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ R&D¿¡ ÅõÀÚÇÏ´Â ÇÑÆí, ÁøÈ­ÇÏ´Â ±ÔÁ¦ Ç¥ÁØÀ» ÁؼöÇÏ°í »ý»ê ºñ¿ëÀ» °ü¸®Çϱâ À§ÇØ ºñ¿ë È¿À²¼ºÀ» ³ô¿©¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 139¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 154¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 281¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 10.51%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀǾàǰ ¿À¿° ¹æÁö¸¦ À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ½Ã³ª¸®¿À
    • ¸¸¼º ÁúȯÀÇ À¯Çà°ú Æ÷Àå ¼Ö·ç¼ÇÀÇ ¹ßÀü
    • ¹Ì¸® ä¿öÁø ÁÖ»ç±â ¼ºÀå
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • À¯¸®°ü ¿ë±â ³»ºÎ Ç¥¸é¿¡¼­ È­Çй°Áú ¹æÃâ
    • ¿ø·á °¡°Ý º¯µ¿ ¹× »ç¿ë °¡´ÉÇÑ ¿ø·áÀÇ ÇѰè
  • ½ÃÀå ±âȸ
    • À¯¿¬ÇÑ ¹«±Õ ÃæÀüÀ» À§ÇÑ Áï½Ã »ç¿ë °¡´ÉÇÑ À¯¸® ¹ÙÀ̾Ë
    • ÀÚµ¿È­¿Í °°Àº ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü
  • ½ÃÀå °úÁ¦
    • ¹ÙÀÌ¿À ÀÇ·á Æó±â¹° ÀçȰ¿ë

Portre's Five Forces: ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå : Á¦Ç°º°

  • ¾ÚÇÃ
  • ¹é
  • º¸Æ²
  • īƮ¸®Áö
  • ÇÁ¸®ÇÊµå ½Ã¸°Áö
  • ¹ÙÀ̾Ë

Á¦7Àå ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå : ¼ÒÀ纰

  • À¯¸®
  • ÇÃ¶ó½ºÆ½
  • Æú¸®¸Ó
  • PVC

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºñ°æ±¸ Á¦Ç° Æ÷Àå ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Berry Global Inc.
  • Catalent, Inc.
  • Gerresheimer AG
  • Jiangsu Micsafe Medical Technology Co., Ltd.
  • NIPRO CORPORATION
  • SCHOTT Pharma AG & Co. KGaA
  • SGD S.A.
  • Stevanato Group
  • Terumo Corporation
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • WEGO HOLDING COMPANY LIMITED
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
LSH

The Parenteral Products Packaging Market was valued at USD 13.97 billion in 2023, expected to reach USD 15.43 billion in 2024, and is projected to grow at a CAGR of 10.51%, to USD 28.14 billion by 2030.

The parenteral products packaging market involves the development and supply of containers and materials used for packaging medications administered through non-oral means, such as intramuscular, intravenous, subcutaneous, or intradermal routes. This market is essential due to its critical role in ensuring drug stability, sterility, and safety while facilitating effective distribution and administration. Key applications involve healthcare settings that require precise medication delivery systems, including hospitals, clinics, and home healthcare environments, with end-users ranging from pharmaceutical and biotechnology companies to public health agencies. The growth of this market is propelled by factors like the increasing prevalence of chronic diseases, advancements in biologics, and a growing need for innovative drug delivery solutions. Additionally, an aging population worldwide fuels demand for these packaging solutions due to increased reliance on injectable drugs. Opportunities include advancements in material science resulting in more sustainable and eco-friendly packaging options and the incorporation of smart packaging technologies to enhance drug tracking and patient adherence. Protective packaging that enhances product shelf life and user-friendly designs also represents significant potential areas. However, market growth is challenged by stringent regulatory requirements, high packaging material costs, and the risk of contamination or product recalls. The complexity of biologics and biosimilars further adds to these challenges, necessitating high levels of compliance. Innovation in this sector can thrive through research dedicated to developing sustainable materials and self-administering packages that increase patient safety and convenience. The market presents a highly dynamic landscape characterized by rapid technological advancements and a focus on sustainability and patient-centered solutions. Companies aiming to stay competitive should invest in R&D to develop next-generation packaging solutions while ensuring compliance with evolving regulatory standards and enhancing cost-efficiency to manage production expenses.

KEY MARKET STATISTICS
Base Year [2023] USD 13.97 billion
Estimated Year [2024] USD 15.43 billion
Forecast Year [2030] USD 28.14 billion
CAGR (%) 10.51%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Parenteral Products Packaging Market

The Parenteral Products Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Stringent regulatory scenarios for prevention of drug contamination
    • Prevalence of chronic diseases and advancements in packaging solutions
    • Growth of prefilled syringes
  • Market Restraints
    • Chemicals release of the internal surface of glass tubing containers
    • Fluctuating price and limited availability of raw material
  • Market Opportunities
    • Ready-to use glass vials for flexible aseptic filling
    • Rapid advancement of technologies like automation
  • Market Challenges
    • Recycling of bio-medical waste

Porter's Five Forces: A Strategic Tool for Navigating the Parenteral Products Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Parenteral Products Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Parenteral Products Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Parenteral Products Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Parenteral Products Packaging Market

A detailed market share analysis in the Parenteral Products Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Parenteral Products Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Parenteral Products Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Parenteral Products Packaging Market

A strategic analysis of the Parenteral Products Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Parenteral Products Packaging Market, highlighting leading vendors and their innovative profiles. These include Baxter International, Inc., Becton, Dickinson and Company, Berry Global Inc., Catalent, Inc., Gerresheimer AG, Jiangsu Micsafe Medical Technology Co., Ltd., NIPRO CORPORATION, SCHOTT Pharma AG & Co. KGaA, SGD S.A., Stevanato Group, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, WEGO HOLDING COMPANY LIMITED, West Pharmaceutical Services, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Parenteral Products Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Ampoules, Bags, Bottles, Cartridges, Prefilled Syringes, and Vials.
  • Based on Material, market is studied across Glass, Plastic, Polymer, and PVC.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Stringent regulatory scenarios for prevention of drug contamination
      • 5.1.1.2. Prevalence of chronic diseases and advancements in packaging solutions
      • 5.1.1.3. Growth of prefilled syringes
    • 5.1.2. Restraints
      • 5.1.2.1. Chemicals release of the internal surface of glass tubing containers
      • 5.1.2.2. Fluctuating price and limited availability of raw material
    • 5.1.3. Opportunities
      • 5.1.3.1. Ready-to use glass vials for flexible aseptic filling
      • 5.1.3.2. Rapid advancement of technologies like automation
    • 5.1.4. Challenges
      • 5.1.4.1. Recycling of bio-medical waste
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Parenteral Products Packaging Market, by Product

  • 6.1. Introduction
  • 6.2. Ampoules
  • 6.3. Bags
  • 6.4. Bottles
  • 6.5. Cartridges
  • 6.6. Prefilled Syringes
  • 6.7. Vials

7. Parenteral Products Packaging Market, by Material

  • 7.1. Introduction
  • 7.2. Glass
  • 7.3. Plastic
  • 7.4. Polymer
  • 7.5. PVC

8. Americas Parenteral Products Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Parenteral Products Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Parenteral Products Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Baxter International, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Berry Global Inc.
  • 4. Catalent, Inc.
  • 5. Gerresheimer AG
  • 6. Jiangsu Micsafe Medical Technology Co., Ltd.
  • 7. NIPRO CORPORATION
  • 8. SCHOTT Pharma AG & Co. KGaA
  • 9. SGD S.A.
  • 10. Stevanato Group
  • 11. Terumo Corporation
  • 12. Vetter Pharma-Fertigung GmbH & Co. KG
  • 13. WEGO HOLDING COMPANY LIMITED
  • 14. West Pharmaceutical Services, Inc.
  • 15. Ypsomed AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦